Benefit of the adjunction of rituximab in salvage regimen before autologous stem-cell transplantation in follicular lymphoma at relapse.: A single-centre study

被引：0
|
作者：
Belhadj, K [1 ]
Hicheri, Y [1 ]
Pautas, C [1 ]
El Gnaoui, T [1 ]
Hémery, F [1 ]
Copie-Bergman, C [1 ]
Beaumont, JL [1 ]
Delfau-Larue, MH [1 ]
Dupuis, J [1 ]
Gaillard, I [1 ]
Diviné, M [1 ]
Reyes, F [1 ]
Haioun, C [1 ]
机构：
[1] Hop Henri Mondor, F-94010 Creteil, France
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] Benefit of the adjunction of rituximab in salvage regimen before autologous stem-cell transplantation (ASCT) in follicular lymphoma at relapse.: A single institution study.
    Belhadj, K
    Hicheri, Y
    Pautas, C
    El Gnaoui, T
    Hémery, F
    Copie-Bergman, C
    Beaumont, JL
    Delfau-Larue, MH
    Dupuis, J
    Gaillard, I
    Diviné, M
    Reyes, F
    Haioun, C
    BLOOD, 2005, 106 (11) : 587A - 587A
  • [2] BENEFIT OF RITUXIMAB BEFORE AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) AT TIME OF RELAPSE IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL)
    Belhadj, K.
    Hicheri, Y.
    Pautas, C.
    El Gnaoui, T.
    Hemery, F.
    Copie-Bergman, C.
    Beaumont, J-L
    Dupuis, J.
    Gaillard, I.
    Haioun, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 112 - 112
  • [3] Rituximab in autologous stem cell transplantation for follicular lymphoma
    Schmitz, N
    ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
  • [4] Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era
    Tam, Constantine S.
    Herschtal, Alan
    Dickinson, Michael
    George, Anupkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3166 - 3167
  • [5] Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation
    Ozkaynak, MF
    Jayabose, S
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2004, 21 (02) : 107 - 113
  • [6] INFLUENCE OF PRIOR EXPOSURE TO RITUXIMAB ON RESULTS OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED OR REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: SINGLE-CENTRE EXPERIENCE
    Redondo Guijo, A. M.
    Martin, A.
    Gonzalez, M.
    Gutierrez, N.
    Vidriales, B.
    Sebastian, E.
    Martin, A. A.
    Guardado, L. A.
    Rojas, S.
    San Miguel, J. F.
    Caballero, D.
    ANNALS OF ONCOLOGY, 2011, 22 : 168 - 168
  • [7] Chemotherapy Versus Autologous Stem-Cell Transplantation for the Treatment of Transformed Follicular Lymphoma in the Rituximab Era Reply
    Panzarella, Tony
    Villa, Diego
    Kuruvilla, John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3167 - 3168
  • [8] RISK FACTORS IN AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA : A SINGLE-CENTRE EXPERIENCE
    Milunovic, V.
    Patekar, M.
    Zatezalo, V.
    Radic-Kristo, D.
    Planinc-Peraica, A.
    Jaksic, B.
    Kolonic, S.
    HAEMATOLOGICA, 2013, 98 : 571 - 572
  • [9] Alemtuzumab-ESHAP as salvage regimen in refractory T-cell lymphoma patients candidate to intensification with autologous or allogeneic stem cell transplantation (a short single-centre pilot study)
    Beaussant, Y.
    Viel, E.
    Ledu, K.
    Legrand, F.
    Deconinck, E.
    Brion, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S425 - S425
  • [10] Autologous stem cell transplantation for high-risk lymphoma -: a single-centre experience
    Theorin, N
    Radlund, A
    Seger-Mollén, A
    Juliusson, G
    Malm, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S351 - S351
12345